Screener
Arcus Biosciences RCUS Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $150M-39.5% | $201M+4.7% | $222M+48.0% | $238M+18.4% | $248M+59.0% | ||
| $552M-16.7% | $621M-22.9% | $759M-8.3% | $593M-33.2% | $663M-18.5% | ||
| $756M-20.1% | $844M-18.1% | $1.01B-0.9% | $857M-24.0% | $946M-7.4% | ||
| $36M-18.2% | $38M-17.4% | $40M-14.9% | $42M-12.5% | $44M-10.2% | ||
| $924M-14.0% | $997M-13.8% | $1.14B-1.0% | $974M-22.2% | $1.08B-9.4% | ||
| $34M+17.2% | $39M+77.3% | $42M+133% | $42M+223% | $29M+93.3% | ||
| $19M-73.2% | $34M-52.8% | $35M-58.8% | $52M-50.5% | $71M-37.2% | ||
| $198M-5.7% | $209M+8.9% | $231M+2.2% | $235M+9.3% | $210M+5.5% | ||
| $101M+4.1% | $100M+108% | $99M+106% | $98M+109% | $97M— | ||
| 400M0.0% | 400M0.0% | 400M-75.3% | 400M0.0% | 400M0.0% | ||
| -$1.7B-37.0% | -$1.61B-29.7% | -$1.49B-31.2% | -$1.38B-32.9% | -$1.24B-31.5% | ||
| $464M-15.5% | $524M-1.3% | $631M+30.1% | $436M-22.8% | $549M-13.5% | ||
| $924M-14.0% | $997M-13.8% | $1.14B-1.0% | $974M-22.2% | $1.08B-9.4% |
FAQ
- What are Arcus Biosciences's total assets?
- Arcus Biosciences (RCUS) holds $924.0M in total assets, down 14.1% year over year.
- How much debt does Arcus Biosciences have?
- Arcus Biosciences carries $114.0M in total debt against $464.0M of shareholders' equity, a debt-to-equity ratio of 0.25.
- How much cash does Arcus Biosciences have?
- Arcus Biosciences holds $150.0M in cash and equivalents.
- Can Arcus Biosciences cover its short-term obligations?
- Its current ratio is 3.82 — current assets exceed current liabilities.
- Where does Arcus Biosciences's balance sheet data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
